Overjet Raises $42.5M in Series B Funding; Reaching $425M Valuation

Figure: Overjet’s Clinical Intelligence Platform displays a radiograph with dental artificial intelligence findings. (PRNewsfoto/Overjet)

Overjet, a Boston, MA-based dental artificial intelligence (AI) software provider raised $42.5m in Series B financing, reaching a $425M valuation.

The round was led by General Catalyst and Insight Partners with participation from existing investors Crosslink Capital and the MIT-affiliated E14 Fund.

The company, which has raised nearly $80m in total financing to date, intends to use the funds to expand operations and its business reach.

Led by Dr. Wardah Inam, PhD, CEO and co-founder, Overjet provides dental AI technology that encodes dentist-level understanding of disease identification and progression into software, supporting dentists to deliver the best patient care and insurers to operate accurately and efficiently. Earlier this year, Overjet secured FDA clearance for its Dental AssistTM product. The company is working with both large dental organizations and single-site clinics to roll out Dental Assist. In October, Overjet and New England Family Dentistry announced a partnership to bring dental AI to the organization’s 50 clinic network.

On the insurance side, Overjet counts 16 major carriers as customers for coverage of over 73 million Americans.